10 biventricular pacemakers from Medtronic gain FDA OK for wider use

04/11/2014 | Medscape (free registration)

Medtronic has secured expanded FDA approval for 10 of its biventricular pacemakers -- the Consulta CRT-P and CRT-D, Brava CRT-D, Syncra CRT-P, Concerto II CRT-D, Viva XT CRT-D and S CRT-D, Protecta CRT-D and XT CRT-D, and Maximo II CRT-D systems. The devices can now be used for patients with atrioventricular block requiring right-ventricular pacing, as well as those with moderate systolic heart failure.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX